Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Wright

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|December 1, 1995
The implications of depression for pain and disability in rheumatoid arthritisJ C Parker, G E Wright
Journal of Medicinal Chemistry|September 1, 1977
Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracilsN C Brown, J Gambino, G E Wright
Nucleosides & Nucleotides|July 22, 1998
Synthesis and biochemical study of N2-(p-n-butylphenyl)-2'-deoxyguanosine 5'-(alpha,beta-imido)triphosphate (BuPdGMPNHPP): a non-substrate inhibitor of B family DNA polymerasesJ M Stattel, I Yanachkov, G E Wright
Biochemical Pharmacology|November 27, 1995
Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?S H Burstein, J K Young, G E Wright
Drugs Under Experimental and Clinical Research|January 1, 1986
Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerasesN C Brown, L W Dudycz, G E Wright
The American Journal of Medicine|June 1, 1977
Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United StatesA Z Lane, G E Wright, D C Blair
Biochemical Pharmacology|March 15, 1986
Solvent interactions with N, N-dialkylnicotinamides and their effects on rotational barriersJ W Bean, D J Nelson, G E Wright
Nucleic Acids Research|April 11, 1991
The molecular mechanism of inhibition of alpha-type DNA polymerases by N2-(butylphenyl)dGTP and 2-(butylanilino)dATP: variation in susceptibility to polymerizationN N Khan, G E Wright, N C Brown
American Journal of Hospital Pharmacy|July 1, 1985
Simple stability-indicating assay for histamine solutionsR K Marwaha, B F Johnson, G E Wright
Nucleic Acids Research|December 9, 1985
Differential inhibition of human placental DNA polymerases delta and alpha by BuPdGTP and BuAdATPM Y Lee, N L Toomey, G E Wright
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|December 1, 1995
The implications of depression for pain and disability in rheumatoid arthritisJ C Parker, G E Wright
Journal of Medicinal Chemistry|September 1, 1977
Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino)uracils and 6-anilinouracilsN C Brown, J Gambino, G E Wright
Nucleosides & Nucleotides|July 22, 1998
Synthesis and biochemical study of N2-(p-n-butylphenyl)-2'-deoxyguanosine 5'-(alpha,beta-imido)triphosphate (BuPdGMPNHPP): a non-substrate inhibitor of B family DNA polymerasesJ M Stattel, I Yanachkov, G E Wright
Biochemical Pharmacology|November 27, 1995
Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?S H Burstein, J K Young, G E Wright
Drugs Under Experimental and Clinical Research|January 1, 1986
Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerasesN C Brown, L W Dudycz, G E Wright
The American Journal of Medicine|June 1, 1977
Ototoxicity and nephrotoxicity of amikacin: an overview of phase II and phase III experience in the United StatesA Z Lane, G E Wright, D C Blair
Biochemical Pharmacology|March 15, 1986
Solvent interactions with N, N-dialkylnicotinamides and their effects on rotational barriersJ W Bean, D J Nelson, G E Wright
Nucleic Acids Research|April 11, 1991
The molecular mechanism of inhibition of alpha-type DNA polymerases by N2-(butylphenyl)dGTP and 2-(butylanilino)dATP: variation in susceptibility to polymerizationN N Khan, G E Wright, N C Brown
American Journal of Hospital Pharmacy|July 1, 1985
Simple stability-indicating assay for histamine solutionsR K Marwaha, B F Johnson, G E Wright
Nucleic Acids Research|December 9, 1985
Differential inhibition of human placental DNA polymerases delta and alpha by BuPdGTP and BuAdATPM Y Lee, N L Toomey, G E Wright
Pageof 9